Feasibility and Metabolic Effects of a 5:2 Fasting Intervention in Women With Breast Cancer During Radiotherapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The intervention consists of the adoption of a 5:2 intermittent fasting diet during radiotherapy of breast cancer patients. The aim of the study was to assess the feasibility of this intervention and its impact on body composition and selected metabolic blood parameters.
Epistemonikos ID: aa79a9cce4dd5d18207fde2610930e7e1ef02f13
First added on: May 14, 2024